A comprehensive view of Kraig Biocraft Laboratories Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Kraig Biocraft Laboratories concludes spring production trials of BAM-1 recombinant spider silk hybrids, announces parental strains are ready for rapid production expansion; CEO returns to US to enact next stages of spider silk production expansion plan
Published:
May 07, 2024
by Kraig Biocraft Laboratories Inc.
|
Kraig Biocraft Laboratories signs key agreements with Lam Dong Agro-Forestry Research Experiment Center in Vietnam on rearing, breeding of company's BAM-1 parental silkworm; agreements outline partnership with LAREC to integrate Kraig's silk technologies
Published:
April 29, 2024
by GlobeNewswire
|
Kraig Biocraft Laboratories completes rearing of first generation of its new BAM-1 parental strains as part of its spring production trial; Kraig Labs successfully produced recombinant cocoons at rates that exceeded trial expectations, control parameters
Published:
April 22, 2024
by GlobeNewswire
|
Kraig Biocraft Laboratories announces that spring production trials for the new BAM-1 hybrid have begun and are on track to meet company's expectations, timeline; BAM-1 is Kraig Labs' newest, most robust recombinant spider silk production silkworm hybrid
Published:
April 15, 2024
by Kraig Biocraft Laboratories Inc.
|
KRAIG BIOCRAFT LABORATORIES, INC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 01, 2024
by SEC Edgar Filings
|
Ask us about our R&D/Patents market view